Product Manager - Oncology

Eris Lifesciences is seeking a Product Manager – Oncology to manage end-to-end product lifecycle, develop competitive brand strategies, and drive market penetration. The involves deep market understanding, cross-functional collaboration, and execution of marketing programs to maximize business performance.

Roles and Responsibilities:

• Analyze market trends, competitor landscape, and customer insights toentify growth opportunities
• Develop and implement brand strategies, positioning, and marketing mix for oncology portfolio
• Plan and execute promotional campaigns, marketing programs, and product launches
• Manage complete product lifecycle including line extensions and portfolio optimization
• Utilize data analytics and market research to support strategic decision-making
• Design and develop promotional materials and communication strategies
• Segment target customers andentify high-potential market opportunities
• Train and support field force to ensure effective execution of marketing strategies
• Collaborate with sales, supply chain, and regulatory teams for seamless operations
• Drive customer engagement initiatives and build strong relationships with key stakeholders
• Monitor sales performance, ROI, and profitability of assigned brands
• Ensure compliance with regulatory guidelines and organizational policies
• Continuously update knowledge on oncology market trends and industry developments

Eris Lifesciences Ltd is a publicly listed Indian pharmaceutical company and a prominent player in the domestic branded formulations market. Ranked among the top companies in the Indian Pharmaceutical Market (IPM), Eris has built a strong presence in the cardio-metabolic segment within a relatively short span since its inception.

Founded with a vision to make a meaningful impact in the management of chronic diseases, the company has evolved into a well-established organization focused on specialist and super-specialist segments. Over the years, Eris has strengthened its leadership across key therapies while maintaining high prescription credibility among healthcare professionals. The company continues to emphasize scientific engagement and patient-centric initiatives to enhance clinical outcomes.

Growth & Strategic Expansion

In recent years, the company has taken significant steps to expand its portfolio and strengthen its market position:

• Entry into the injectables segment, a high-growth market in India
• Acquisition of Swiss Parenterals, adding:
  • 190+ molecules
  • Pipeline of 40+ new products
• Acquisition of Biocon’s India Branded Formulation business, enhancing:
  • Insulin portfolio with key brands like Basalog and Insugen
  • Presence in the critical care segment
• Strategic entry into the oncology segment, including monoclonal antibody portfolio